In this study, we show that introduction of human N-acetylglucosaminyltransferase (GnT)-III gene into tobacco plants leads to highly efficient synthesis of bisected N-glycans. Enzymatically released N-glycans from leaf glycoproteins of wild-type and transgenic GnT-III plants were profiled by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) in native form. After labeling with 2-aminobenzamide, profiling was performed using normal-phase high-performance liquid chromatography with fluorescence detection, and glycans were structurally characterized by MALDI-TOF/TOF-MS and reversephase nano-liquid chromatography-MS/MS. These analyses revealed that most of the complex-type N-glycans in the plants expressing GnT-III were bisected and carried at least two terminal N-acetylglucosamine (GlcNAc) residues in contrast to wild-type plants, where a considerable proportion of N-glycans did not contain GlcNAc residues at the nonreducing end. Moreover, we have shown that the majority of N-glycans of an antibody produced in a plant expressing GnT-III is also bisected. This might improve the efficacy of therapeutic antibodies produced in this type of transgenic plant.
Introduction
The initial steps of N-glycosylation of proteins in plants and animals, which take place in the endoplasmic reticulum, are very similar. However, on reaching the Golgi complex, this process starts to differ between and within both types of organisms, depending on tissue type and developmental stage. This variability is mainly the result of differences in the repertoire of Golgi-localized glycosyltransferases encoded by these organisms (Wilson 2002; Gomord and Faye 2004) . A whole range of typical mammalian glycosyltransferases including, for example, b1,4-galactosyltransferase 1 (GalT) does not occur in plants, although human GalT can be expressed ectopically in tobacco plants using genetic modification as shown previously Bakker et al. 2006) . Conversely, core b1,2-xylosyltransferase (XylT), for example, appears to be ubiquitous in plants, but seems to absent in most animals except snails and helminths (van Kuik et al. 1985; Khoo et al. 1997) .
N-acetylglucosaminyltransferase III (GnT-III; EC 2.4.1.144) is one such animal enzyme that is lacking in plants. It is responsible for attaching a b1,4-linked N-acetylglucosamine (GlcNAc) residue to the b-linked mannose (Man) of the trimannosyl core; a structure that was first designated a bisecting GlcNAc in 1981 (Carver et al. 1981) . A year before that, it was shown that the last two a1,2-linked Man residues from the hybrid GlcNAc 2 Man 5 GlcNAc 2 , comprising a GlcNAclinked b1,4 and a b-linked Man of the core, could not be removed by mannosidase II (Man-II), which would explain the existence of hybrid structures in ovalbumin (Harpaz and Schachter 1980b) . In the N-glycosylation pathway, the action of GnT-III is preceded by GnT-I with GlcNAcMan 5 GlcNAc 2 and GlcNAc 2 Man 3 GlcNAc 2 constituting the primary acceptors, whereas GlcNAcMan 3 GlcNAc 2 is a relatively poor acceptor (Harpaz and Schachter 1980a; Narasimhan 1982; Schachter et al. 1983; Allen et al. 1984) . The presence of a bisecting GlcNAc residue not only prevents the action of Man-II, but also the action of GnT II (Harpaz and Schachter 1980a) , core a1,6-fucosyltransferase (FucT) (Longmore and Schachter 1982) , and GnT-IV . In addition, it appears that steric hindrance due to the bisecting GlcNAc may cause reduced galactosylation of the a1,3 arm, although GalT is not completely prevented from functioning unlike the above-mentioned enzymes (Narasimhan et al. 1985) . On the other hand, GnT-III activity is completely inhibited by the presence of a b1,4-linked galactose (Gal) attached to the GlcNAc residue of the a1,3-arm of GlcNAc 2 Man 3 GlcNAc 2 .
The gene encoding the rat GnT-III was the first one of its kind to be cloned and was later found to be 91% identical to its human homolog at the amino acid level (Nishikawa et al. 1992; Ihara et al. 1993 ). Overexpression of GnT-III in Chinese hamster ovary (CHO) cells used for the production of a monoclonal antibody (mAb) caused high levels of bisected N-glycans, which improved the therapeutic value of the product by increasing its antibody-dependent cellular cytotoxicity (ADCC) activity (Umana et al. 1999) . The goal of this study was to explore the possibility of introducing bisecting GlcNAc residues on plant N-linked glycans through the ectopic expression of a GnT-III gene. In addition, we wanted to examine whether this would lead to reductions in core-bound xylose (Xyl) and fucose (Fuc) on N-glycans of endogenous proteins and an antibody produced in the transgenic plants.
Using matrix-assisted laser desorption/ionization time-offlight mass spectrometry (MALDI-TOF-MS), we provide evidence that almost all N-glycans in tobacco plants expressing the human GnT-III gene are bisected and contain core-bound Xyl. The most remarkable observation, however, was the virtual lack of paucimannosidic structures that are commonly found in wild-type plants. In addition, through reverse-phase nano-liquid chromatography (LC)-MS/MS of glycopeptides of a recombinant antibody produced in a plant expressing GnT-III, we showed that the majority of its N-glycans were also bisected and devoid of paucimannosidic structures.
Results

Selection of transgenic tobacco plants expressing the human GnT-III gene
The gene encoding the human GnT-III was introduced in tobacco plants by Agrobacterium-mediated transformation of the binary vector pBINPLUSGnT-III, containing a copy DNA (cDNA) harboring the complete coding sequence fused to a C-terminal cellular homolog of myelocytomatosis viral oncogene (c-myc) tag under control of the constitutive cauliflower mosaic virus 35S (CaMV35S) promoter. Sixty independent kanamycin-resistant transgenic shoots were obtained; of which, 16 were rooted and transferred to the greenhouse. An immunoblot assay with anti-c-myc antibodies revealed that all transformants displayed similar levels of GnT-III (data not shown). However, it proved to be very difficult to obtain stable progeny with the transgenic trait and only line GnT-III-20-2 has been retained.
Western blot analysis of GnT-III-20-2 Rabbit anti-HRP antibodies bind very strongly and specifically to typical plant N-glycans, and this antibody and its affinity-purified fractions with anti-Xyl and anti-Fuc specificity were used to analyze line GnT-III-20-2 (Kurosaka et al. 1991) . Leaf proteins from line GnT-III-20-2 were compared with leaf proteins from wild-type plants by western blot analysis (Figure 1) . A steep decline in antibody binding to protein from GnT-III-20-2 leaves was observed in the second lanes of each of the three panels in Figure 1 , as compared with the signal from wild-type plants in the first lanes. This suggests that GnT-III expression caused a considerable decrease in the levels of core-bound Xyl and Fuc.
Activity of Arabidopsis thaliana XylT and FucT with bisected acceptor As several mammalian enzymes are inhibited by the presence of a bisecting GlcNAc residue, the plant core b1,2-XylT and core a1,3-FucT (FucT-C3-1) were also tested for their ability to employ an acceptor with bisecting GlcNAc. To this end, the cloned cDNAs corresponding to the Arabidopsis FucT-C3-1 and b1,2-XylT were expressed in CHO cells and homogenates of these cells were tested for activity with a number of acceptors (Table I) . Core a1,3-FucT displayed full activity with the biantennary acceptor, but almost no activity with its bisected version. Core b1,2-XylT was incapable of using this bisected acceptor and had optimal activity with GlcNAcMan 3 GlcNAc 2 . Hence, both enzyme preparations were active with their preferred substrates, but displayed hardly, if any, activity with a bisected substrate.
N-glycan profile of GnT-III expressing plant Proteins were isolated from tobacco wild-type and GnT-III-20-2 plants, cleaved with pepsin, and the N-glycans were released using peptide N-glycosidase A. Released glycans were labeled with 2-aminobenzamide (2-AB), and glycan profiles of wild-type and GnT-III-20-2 plants were compared by normal phase high-performance liquid chromatography (HPLC) with fluorescence detection and this revealed marked differences ( Figure 2 ). Eluting species were analyzed by MALDI-TOF-MS after peak fractionation. Oligosaccharide compositions were deduced from the observed masses. Based on the plant origin of the glycans and the specificity of the glycosyltransferases involved in N-glycosylation, hexoses, N-acetylhexosamines, deoxyhexoses, and pentoses were interpreted as Man, GlcNAc, Fuc, and Xyl, respectively.
The HPLC profile for line GnT-III-20-2 showed three major peaks ( Figure 2B ). A comparison of the HPLC profile with the MALDI-TOF MS indicated that the latter also provided an adequate reflection of the actual N-glycan make-up ( Figure 3 ; Harvey 2003) . For two of the peaks (at 92.0 and 100.3 min), no corresponding peak was detected in the wildtype run (Figure 2A ). On the basis of their composition, the species GlcNAc 3 (Xyl)Man 3 GlcNAc 2 (at 92.0 min) and GlcNAc 3 (Xyl)(Fuc)Man 3 GlcNAc 2 (at 100.3 min) were assumed to be bisecting. For the species GlcNAc 2 (Xyl) Man 3 GlcNAc 2 (87.8 min), a MALDI-TOF/TOF-MS analysis Reverse phase nano-LC-MS of the 2-AB labeled GlcNAc 2 (Xyl)(Fuc)Man 3 GlcNAc 2 fraction from GnT-III-20-2 revealed the presence of two isobaric species, with one being approximately 50 times more abundant than the other (data not shown). The retention times of both species differed from that of GlcNAc 2 (Xyl)(Fuc)Man 3 GlcNAc 2 from the wild-type plant. Differences in fragmentation patterns between wild-type derived GlcNAc 2 (Xyl)(Fuc)Man 3 GlcNAc 2 and the isobaric species from the GnT-III plant are shown in Figure 5 . The doubly-protonated species at m/z 858 was fragmented in the ion-trap (IT) MS and the singly-charged fragment resulting from loss of a GlcNAc was fragmented further. The spectra differed considerably and, in Figure 5B , a range of ions at m/z 569.1, 910.3, and 1072.3 can be observed that are typical of a bisected precursor fragment. The high intensity of the ion at m/z 1309.5 in Figure 5A compared with that in Figure 5B and the relatively low intensity of the ion at m/z 1025.3 in Figure 5A compared with that in Figure 5B demonstrate the high stability of the bisecting GlcNAc. The signal at m/z 1171.3 seems to arise from Fuc rearrangements, which are known to occur on Table I . Acceptor specificity of Arabidopsis thaliana recombinant glycosyltransferases a1,3-FucT-C3-1 and b1,2-XylT Acceptor Diagram Enzyme activity (pmol/min per mg protein)
FucT XylT
GP, IgG glycopeptide; ND, not determined. GJA Rouwendal et al. GnT-III dependent synthesis of bisected N-glycans in plants collision-induced dissociated proton adducts (Wuhrer, Koeleman, Hokke, et al. 2006 and references therein) .
N-glycan composition of antibody from GnT-III expressing plant
In order to study the N-glycan profile of an antibody produced in a transgenic line expressing GnT-III, we created a series of new transgenics using the original gene cassette built into a plant transformation vector with a hygromycin resistance marker to allow re-transformation of an existing kanamycin-resistant tobacco plant producing antibody MGR48 (Smant et al. 1997) . A typical line expressing both GnT-III and the antibody was selected from a small group of six transgenics using western blot analysis with anti-HRP and anti-immunoglobulin G (IgG) probes, respectively (data not shown). A MALDI-TOF MS analysis of unlabeled N-glycans from these six lines showed that in all of them between 65% and 75% of N-glycans were in the form of GlcNAc 3 Man 3 (Xyl)(Fuc)GlcNAc 2 (data not shown). Antibody MGR48 was purified from the selected line GIIIMGR5 using protein G and it was shown by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (SDS -PAGE) analysis to be slightly degraded as was found previously for the same antibody from wild-type tobacco plants (data not shown; Stevens et al. 2000) . Glycosylation of the antibody MGR48 purified from GnT-III-expressing tobacco plants was analyzed at the level of tryptic glycopeptides by nano-LC-electrospray ionization (ESI)-IT-MS. The obtained glycopeptide profile for the single N-glycosylation site of the antibody is shown in Figure 6 . In order to be able to register a representative glycopeptide profile, the voltages of the ion transfer region of the mass spectrometer were optimized to avoid in-source decay of the protonated glycoconjugates. Loss of terminal monosaccharides in the ion transfer region can be excluded, as no oxonium ions arising, for example, from chitobiose cleavage were observed in the low mass region. Likewise, no loss of Fuc was observed for the major glycan species (m/z 1469 in Figure 6 ; loss of Fuc would result in a signal at m/z 1396.0, which is not observed), though Fuc is known to be easily lost under harsh ion transfer conditions. On the basis of these considerations, it may be concluded that the observed glycopeptide profile (Figure 6 ) represents native glycan species. MS/MS experiments (Figure 7 and data not shown) showed that the Figure 7) and of deduced structures of released glycans from total tobacco leaf glycoproteins. Glycopeptides were observed as doubly-protonated species. Monoisotopic masses are given rounded to 1 decimal place. For key see Figure 3 ; #, singly-charged species (not glycopeptide related). (Figure 6 ) was subjected to automatic fragment ion analysis using collision-induced dissociation in the IT MS. Singly-and doublyprotonated fragment ions were observed, and monoisotopic masses are given rounded to 1 decimal place. For key, see Figure 3 ; D, elimination of water and/or ammonia. *, double-charged ion.
GnT-III dependent synthesis of bisected N-glycans in plants majority of N-glycans linked to the constant region of antibody molecule (Fc) of the heavy chain were bisected. For example, fragment ion analysis of the most abundant tryptic glycopeptide at m/z 1469.0 revealed the presence of two ions at m/z 569.2 and 964.9, both of which are typical of bisected structures (Figure 7) . However, in contrast to the complextype N-glycans from endogenous proteins in line GnT-II-20-2, which were all bisected, at least one of the antibody N-glycans from line GIIIMGR5 at m/z 1228.4 was not bisected as determined by fragment ion analysis (data not shown). Moreover, in contrast to N-glycans from total protein from line GnT-III-20-2, the oligosaccharides from the antibody contained clearly detectable amounts of bisected species in which the only core-bound substitution consisted of Fuc. In addition, highMan-type N-glycans appeared to be more prevalent in the antibody than in the glycoprotein content as a whole.
Discussion
To our knowledge, the synthesis of bisected N-glycans in transgenic tobacco plants expressing the human GnT-III gene reported here is only the second example of typical animal N-glycans being synthesized in transgenic plants (Palacpac et al. 1999; . The N-glycan profile of the GnT-III-20-2 line is made up of four major complex-type N-glycans, two of which are definitely biantennary with a bisecting GlcNAc, as judged by their m/z value. The other two also contained a bisecting GlcNAc, as was shown by detailed MALDI-TOF/TOF MS and nano-LC-MS/MS analyses. Hence, we conclude that most complextype N-glycans in this line are bisected. The extraordinarily high level of this type of oligosaccharide in this line, as well as in the other randomly selected transgenics expressing the mAb, suggests that the enzyme acts very efficiently in a plant cell environment.
The absence of hybrid N-glycans could mean either that GnT-III does not act at early stages of Golgi-localized N-glycosylation or that plant Man-II and GnT-II are able to cope with the bisected acceptors GlcNAc 2 Man 5 GlcNAc 2 and GlcNAc 2 Man 3 GlcNAc 2 , respectively. This is in contrast to their animal counterparts (Harpaz and Schachter 1980b; Allen et al. 1984; Bendiak and Schachter 1987) . Support for the hypthesis of a late-acting GnT-III came from the observations that both the core b1,2-XylT and FucT-C3-1 could not function with a bisected, biantennary acceptor, while all complex N-glycans contained core-bound Xyl and frequently Fuc as well. Consequently, addition of Xyl and Fuc probably preceded that of a bisecting GlcNAc. Further support for a late-acting GnT-III can be deduced from the observation that efficient xylosylation requires core b1,2-XylT to act before core a1,3-FucT, and since core b1,2-XylT is concentrated mainly in the medial-Golgi compartment, core a1,3-FucT is then likely to be localized beyond this compartment and possibly in the vicinity of GnT-III (Pagny et al. 2003; Bencúr et al. 2005) . The colocalization of FucT and GnT-III is also corroborated by the presence of a substantial fraction of Nglycans lacking core-bound Fuc in GnT-III plants relative to wild-type plants. This suggests that GnT-III regularly prevails over core a1,3-FucT and that the distribution of GnT-III and core a1,3-FucT in transgenic plants is overlapping. In mammalian cells, GnT-III activity must be restricted to the later stages of N-glycosylation in the trans-Golgi compartment, as it would otherwise interfere with proper processing of N-glycans to biantennary molecules. Interference with normal processing can be inferred, for example, from experiments in which a chimeric GnT-III, comprising the N-terminal cytoplasmic transmembrane stem (CTS)-region from a medial-Golgi enzyme expressed in mammalian cells and purportedly shifting localization to earlier stages of N-glycosylation, caused the formation of hybrid N-glycans . All in all, it is likely that human GnT-III produced in plant cells is also localized in the trans-Golgi compartment similar to core FucT (Fitchette-Lainé et al. 1994) .
High levels of bisected GlcNAc 2 (Xyl)Man 3 GlcNAc 2 and GlcNAc 2 (Xyl)(Fuc)Man3GlcNAc2 peaks are due to either removal of a GlcNAc residue from one of the arms or incomplete processing. Unfortunately, we do not know the identity of the two isobaric 2-AB-labeled GlcNAc 2 (Xyl)Man 3 GlcNAc 2 species found in GnT-III-20-2, one of which being present in trace amounts compared with the other. In one species, the GlcNAc of the a1,3-arm seems to be missing, whereas in the other, the GlcNAc of the a1,6 arm is absent. As addition of Xyl, Fuc, and bisecting GlcNAc depend on the presence of the GlcNAc on the a1,3-arm, lack of GlcNAc linked to the a1,3-arm in any GlcNAc 2 (Xyl)Man 3 GlcNAc 2 species must be due to the action of an hexosaminidase (Tezuka et al. 1992; Leiter et al. 1999) . Two insect hexosaminidases have been discovered that preferentially, or even exclusively, remove the b1,2-linked GlcNAc from the Man(a1,3)-arm and homologous Arabidopsis hexosaminidase genes have been identified (Léonard et al. 2006; Tomiya et al. 2006) . The isobaric species without the GlcNAc on the a1,6-arm could be due to degradation of GlcNAc 3 (Xyl) Man 3 GlcNAc 2 by hexosaminidase activity as well, but we could not rule out a defect in biosynthesis whereby addition of a bisecting GlcNAc immediately following the actions of Man-II, core b1,2-XylT, and core a1,3-FucT might create an acceptor that would be as unsuitable for the plant GnT-II as it would be for its animal counterpart (Bendiak and Schachter 1987) . Irrespective of the exact configuration of the bisected N-glycans in which one of the antennae is missing a GlcNAc residue, it is clear that the typical wild-type paucimannosidic N-glycans (Xyl)(Fuc)Man 3 GlcNAc 2 and GlcNAc(Xyl)(Fuc)Man 3 GlcNAc 2 ) are completely lacking in the GnT-III plants. Apparently, the bisecting residue provides considerable protection to the hexosaminidase-mediated cleavage of GlcNAc on one of the antennae.
Previously, we have shown that expression of a hybrid GalT (b1,4-GalT) in tobacco caused a sharp reduction in the binding of anti-HRP to proteins of those transgenic plants concomitant with a strong reduction in the levels of corebound Xyl and Fuc residues in their N-glycans (Bakker et al. 2006) . Although the lack of anti-HRP binding to proteins from line GnT-III-20-2 also suggested a strong reduction in core-bound Xyl and Fuc residues, the MALDI-TOF MS data demonstrated unequivocally that reduced binding was very likely due to shielding of the core-bound epitopes by both terminal GlcNAc residues and not to a decline of the levels of core-bound Xyl and Fuc. Indeed, even wild-type biantennary N-glycans with terminal GlcNAc on both antennae already lead to severe steric hindrance of antibody binding (Bencúrová et al. 2004 ).
GJA Rouwendal et al.
Coexpression of genes encoding GnT-III and a therapeutic antibody in mammalian human embryonic kidney 293-Epstein -Barr virus nuclear antigen cells yields antibodies with hybrid and complex glycans, most of which are bisected and fucosylated. In this expression system, the use of a chimeric GnT-III with the CTS region of Man-II yields antibodies with bisected, hybrid glycans that are almost completely devoid of core-bound Fuc and achieve a highly increased ADCC compared with the unmodified antibody (Shields et al. 2002; Shinkawa et al. 2003; . High-affinity binding of glyco-engineered nonfucosylated antibodies to FcgRIIIA may be due to the fact that the receptor is able to approach the Fc more closely in the absence of the a1,6-Fuc. It is unknown how the interaction between plant-made antibodies with N-glycans substituted with a1,3-Fuc or b1,2-Xyl and the FcgRIIIA receptor is affected, let alone in the presence of a bisecting GlcNAc.
Earlier analyses of MGR48 produced in wild-type tobacco have already shown that the N-glycans of this antibody contained much less core-bound substitutions than the endogenous glycoproteins . In fact, production of MGR48 in a glyco-engineered tobacco expressing a hybrid GalT gene yielded antibodies with little, if any, N-glycans containing core-bound Xyl and Fuc (Bakker et al. 2006) . The nano-LC-ESI-IT-MS analysis of tryptic EEQFNSTFR-glycopeptides from MGR48 prepared from a GnT-III expressing line showed that a major fraction contained one or both core modifications in addition to a significant fraction carrying high-Man-type N-glycans. The occurrence of slightly higher levels of high-Man-type N-glycans linked to MGR48 antibodies has been observed before and appeared to be highest in antibody preparations from relatively young upper leaves . The fact that MGR48 antibody from the GnT-III expressing plant did comprise an N-glycan species with Fuc as the only core substitution is somewhat remarkable, because this structure did not occur to a significant extent on total protein. Hence, as far as N-glycan synthesis on MGR48 antibody in a GnT-III plant is concerned, and especially with respect to the role of core b1,2-XylT, core a1,3-FucT, and GnT-III, compartmentalization of these glycosyltransferases appears to be much less distinct than in Nglycan synthesis on the whole. For example, in order to arrive at the glycopeptides at m/z 1301.5 and 1403.0 (Figure 6 ), the supposedly late-acting GnT-III must have acted earlier than XylT, which has been shown to accumulate in the medial-Golgi compartment. Nevertheless, the most abundant glycopeptide carried a bisected N-glycan with both core modifications indicating that in this case, XylT and FucT acted before GnT-III. It remains to be seen whether the core a1,3-Fuc, characteristic of the majority of plant Nglycans on antibody molecules from GnT-III expressing plants, interferes with high-affinity binding of such an antibody to FcgRIIIa in the same way as the core a1,6-Fuc found in mammalian IgG antibodies (Ferrara, Stuart, et al. 2006 ).
Materials and methods
Plasmids and plant transformation
The human gene for GnT-III was cloned from P1-derived artificial chromosome (PAC) clone RPI5-1104-E15 by polymerase chain reaction using AccuTaq LA DNA polymerase (Sigma-Aldrich, Zwijadrecht, The Netherlands) and primers GNT3F (5 0 -TACTCGAGTTAACAATGAAGATG-AGACGCT-3 0 ) and GNT3Rmyc (5 0 -TATGGATCCTAA TTCAGAT CCTCTTCTGAGATGAG-3 0 ). The resulting fragment was cloned in EcoRV site of pBluescribe SKþ (Stratagene, La Jolla, CA) and the sequence was verified. A 1.6 kb HpaI/BamHI fragment containing the GnT-III gene with C-terminal c-myc tag was subsequently cloned into the SmaI/BglII site of pUCAP35S (van Engelen et al. 1995) . The CaMV35S promoter expression cassette with modified GnT-III gene was subsequently cloned as a AscI/PacI fragment either in the binary vector pBINPLUS or in the pMOG22, which had been modified to contain a multiple cloning site flanked by AscI/PacI sites (van Engelen et al. 1995; Goddijn et al. 1993) . The vectors were introduced in Agrobacterium tumefaciens strains Agl0 or LBA4404, respectively, by electroporation. Transformation of Nicotiana tabacum variety Samsun NN wild-type or homozygous transgenic plants MGR48-31-4 producing the mAb MGR48 was carried out as described before Bakker et al. 2006) . Transgenic plants were selected and grown to maturity in the greenhouse at 218C.
Western blot analysis
Protein extracts were prepared by grinding two leaf discs per plant to fine powder in a 1.5 mL Eppendorf tube under liquid nitrogen. For lectin blotting, 250 mL of SDS-PAGE loading buffer [20 mM Tris -HCl, pH 6.8, 6% (v/v) glycerol, 0.4% (w/v) SDS, 2.5 mg/mL bromophenol blue] containing 5% (v/v) b-mercaptoethanol was mixed with the frozen powder, and the contents were boiled immediately for 5 min. The samples were centrifuged for 2 min at 20 800g and 17.5 mL of supernatant was loaded onto a 10% SDS-PAGE gel. Protein was transferred onto nitrocellulose as described previously (Faye et al. 1993; Bakker, Schijlen, et al. 2001) . Equal loading was verified using Ponceau S staining of the blot. Immunological detection of plant glycoproteins was performed with rabbit anti-HRP-IgG (Rockland, Gilbertsville, PA) and Xyl-and Fucspecific fractions thereof followed by HRP-conjugated goat anti-rabbit-IgG . Signals were visualized using chemiluminescent substrate Lumi-Light (Roche Diagnostics, Almere, The Netherlands) and a Roche Diagnostics Lumi-Imager.
Enzyme assays
Nonsialylated core a1,6-fucosylated glycopeptides from human IgG (ag-GP-IgGF 6 ) were prepared essentially as described in Narasimhan et al. (1979) . The glycopeptides were degalactosylated by treatment with jack bean b-galactosidase (1 unit/10 mmol glycopeptide). Glycopeptides containing a bisecting GlcNAc were separated from glycopeptides without a bisecting GlcNAc as described in Narasimhan et al. (1986) . CHO cells were transiently transfected with pABEAt-FucT-C3-1 and pABE-At-XylT cDNA using the calcium phosphate precipitation method (Bakker, Schijlen, et al. 2001) . FucT and XylT assays were performed in a 25 mL reaction mixture containing 2.5 mmol sodium cacodylate (pH 7.0), 0.25 mmol MnCl 2 , 0.1 mmol ATP, 2.5 nmol GDP-[ GnT-III dependent synthesis of bisected N-glycans in plants X-100, 1 mM acceptor substrate, and 5 -10 mL of CHO cell homogenate, as described previously (van Tetering et al. 1999) . Control assays lacking the acceptor substrate were carried out to correct incorporation into endogenous acceptors. After incubation for 60-120 min at 37 8C, the reaction was stopped and the product was separated from unincorporated label by chromatography on a 1 mL column of Dowex-1-X8 according to Nemansky and Van den Eijnden (1993) .
MALDI-TOF(/TOF)-MS
MALDI-TOF(/TOF)-MS data were obtained using an Ultraflex I TOF-MS (Bruker, Daltonics, Bremen, Germany) equipped with a LIFT-MS/MS facility. 6-Aza-2-thiothymine (5 mg/mL; Sigma-Aldrich) was used as a matrix. Spectra were acquired in the positive ion reflectron mode. For fragment ion analysis in the tandem (TOF/TOF) mode, precursors were accelerated to 8 kV and selected in a timed ion gate. Fragment ions arising from metastable decomposition of the precursor were further accelerated by 19 kV in the LIFT cell, and their masses analyzed after the ion reflector passage. External calibration of MALDI-TOF mass spectra was carried out using singly-charged monoisotopic peaks of a mixture of human angiotensin I, bombesin, adrenocorticotropic hormone (ACTH 18-39), and somatostatin-28 (Bruker, Daltonics). For MALDI-TOF/TOF-MS, calibrations were performed using fragment ion spectra obtained for the proton adducts of these peptides.
Normal phase HPLC and reverse phase-nano-LC-MS/MS of 2-AB-labeled glycans N-glycans were purified as described previously (Bakker et al. 2006) . Labeling of glycans with 2-AB and normal phase-HPLC analysis with fluorescence detection was performed as described before (Wuhrer et al. 2004 ). Peakfractions were collected and analyzed by MALDI-TOF (/TOF)-MS [see MALDI-TOF(/TOF)-MS section] and reverse phase nano-LC-MS/MS as described previously (Wuhrer, Koeleman, Deelder, et al. 2006) .
Glycopeptide analysis MGR48 antibody purified from GnT-III-expressing plants was incubated with 1 mg trypsin (Promega, Leiden, The Netherlands) at 37 8C overnight . The resulting (glyco-)peptide samples were applied to a reverse-phase column (C18 PepMap 100 Å , 3 mm, 75 mm Â 150 mm; Dionex/LC Packings, Amsterdam, The Netherlands) using an Ultimate nano-LC system, a Famos autosampler, and a Switchos trap-column system (Dionex/LC Packings). The column was equilibrated at room temperature with eluent A (0.1% formic acid in water) at a flow rate of 150 nL/min. After injection of the sample, a gradient was applied to 50% eluent B (95% acetonitrile and 0.1% formic acid) in 30 min followed by an isocratic elution with 50% eluent B for 15 min. The eluate was monitored by absorption at 215 nm.
The LC column was coupled to an Esquire HCT ultra ESI-IT-MS (Bruker, Daltonics) equipped with an online nanospray source operating in the positive ion mode. For electrospray (1100-1250 V), capillaries (360 mm outer diameter, 20 mm inner diameter with 10 mm opening) from New Objective (Cambridge, MA) were used. The solvent was evaporated at 175 8C employing a nitrogen stream of 7 L/ min. Ions from m/z 200 to 2500 were registered. When operated in the auto-MS/MS mode, each MS scan was followed by the acquisition of MS/MS spectra of up to three of the most abundant ions in the MS spectrum.
